A kind of expression infectious laryngotracheitis virus gb gene, its recombinant fowlpox virus and its construction method and application
A technology for laryngotracheitis virus and fowl pox virus, which is applied in the directions of virus, application, virus peptide, etc., can solve the problems of indistinguishability between wild virus strains and vaccine strains, economic loss of poultry industry, and strong virulence of live attenuated vaccines. , to achieve the effect of overcoming virulence reversion and latent infection, large market economic potential, and significant immune protection level
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] Construction of transfer vector
[0050] The fowlpox virus transfer vector p12LS contains two fowlpox virus replication non-essential region genes, MCS and promoter Ps, and can insert the target gene in the transfer vector into the fowlpox virus by using the principle of homologous recombination.
[0051] The mutated plasmid T3-gB was electrophoresed with BamH I and Xho I to recover the target fragment of 2.7 kb, which was ligated with the vector plasmid p12LS cut with BamH I and SalI, and the plasmids, BamH I and Sma I were extracted For double enzyme digestion identification, take the plasmid with the correct band size and send it to Nanjing GenScript Company for sequencing. The positive plasmid is the transfer vector p12LS-gB, and the BamH I+Sma I double enzyme digestion identification result of p12LS-gB is as follows figure 2 Shown, wherein, M: 1kbplus DNAladder; 1: p12LS-gB digested by BamH I+Sma I.
[0052] Transfection and Purification of Recombinant Fowlpox Vi...
Embodiment 2
[0084] recombinant fowl pox virus rFPV 282E4 -gB immune potency
[0085] The 28-day-old SPF chickens were randomly divided into 10 groups, according to 10 5 The dose of PFU / bird was immunized with rFPV respectively 282E4 -gB, fowlpox parental strain wt-FPV 282E4 At the same time, a control group of commercialized ILTV recombinant fowlpox virus genetically engineered vaccine was established, and the dose was 10 5 PFU / rat; PBS control group, the dose was 0.2mL / rat. 21 days after immunization, use 10 5 EID 50 The ILTV wild strain Gallidherpesvirus 1strain I19 per chicken was used for throat challenge, and the morbidity and mortality of each vaccinated chicken were observed, and throat swabs were collected to determine the detoxification situation.
[0086] (1) Clinical scores, morbidity and mortality after challenge
[0087] According to the clinical symptoms of each group of chickens after observing the challenge, carry out clinical scoring, scoring standard: normal=0 poi...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


